Cargando…
Inhibiting 4E-BP1 re-activation represses podocyte cell cycle re-entry and apoptosis induced by adriamycin
Podocyte loss is one of the determining factors for the progression toward glomerulosclerosis. Podocyte is terminally differentiated and does not typically proliferate following injury and loss. However, recent evidence suggested that during renal injury, podocyte could re-enter the cell cycle, sens...
Autores principales: | Li, Fang, Mao, Xing, Zhuang, Qiyuan, Zhao, Zhonghua, Zhang, Zhigang, Wu, Huijuan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6411872/ https://www.ncbi.nlm.nih.gov/pubmed/30858353 http://dx.doi.org/10.1038/s41419-019-1480-x |
Ejemplares similares
-
Yes-associated protein regulates podocyte cell cycle re-entry and dedifferentiation in adriamycin-induced nephropathy
por: Xie, Kewei, et al.
Publicado: (2019) -
Nuclear exclusion of YAP exacerbates podocyte apoptosis and disease progression in Adriamycin-induced focal segmental glomerulosclerosis
por: Zhuang, Qiyuan, et al.
Publicado: (2020) -
Septal hypertrophy and cell cycle re-entry in AD
por: Butler, Tracy, et al.
Publicado: (2019) -
Adriamycin does not damage podocytes of zebrafish larvae
por: Schindler, Maximilian, et al.
Publicado: (2020) -
PARP inhibitor re-sensitizes Adriamycin resistant leukemia cells through DNA damage and apoptosis
por: Wu, Jie, et al.
Publicado: (2019)